Avascular Necrosis Market Report: Trends, Forecast and Competitive Analysis to 2030

Avascular Necrosis Market Report: Trends, Forecast and Competitive Analysis to 2030

Avascular Necrosis Trends and Forecast

The future of the global avascular necrosis market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global avascular necrosis market is expected to reach an estimated $853.8 million by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are growing preference for less painful substitute bone grafting surgical procedures, rising preference for surgeries to treat osteonecrosis, and increasing adoption of nonsteroidal anti-inflammatory drugs.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Avascular Necrosis by Segment

The study includes a forecast for the global avascular necrosis by type, treatment, diagnosis, end use, and region.

Avascular Necrosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Trauma
• Non-Trauma

Avascular Necrosis Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
• Cholesterol Lowing Drugs
• Osteoporosis Drugs
• Blood Thinners
• Others

Avascular Necrosis Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

• Imaging
• Biopsy
• CT Scan
• PET
• X- Ray

Avascular Necrosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Avascular Necrosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Avascular Necrosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies avascular necrosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the avascular necrosis companies profiled in this report include-

• Novartis
• Pfizer
• Teva Pharmaceutical
• Mylan
• Zimmer Biomet
• Merck
• Enzo Biochem
• Atnahs
• Bone Therapeutics
• Vericel

Avascular Necrosis Market Insights

Lucintel forecasts that non-trauma will remain the larger segment over the forecast period due to its rising usage among various treatments related to alcohol intake and abnormalities related to metabolism of bones.

Within this market, hospital pharmacy is expected to witness the highest growth due to increasing number of hospitalized patients opting for non-invasive therapy and surgery to treat osteonecrosis.

North America will remain the largest region over the forecast period due to rising cases of avascular necrosis among individuals, increase in geriatric population, and presence of key players in the region.

Features of the Global Avascular Necrosis Market

Market Size Estimates: Avascular necrosis market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Avascular necrosis market size by various segments, such as by type, treatment, diagnosis, end use, and region in terms of value ($M).

Regional Analysis: Avascular necrosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, treatments, diagnosis, end uses, and regions for the avascular necrosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the avascular necrosis market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the avascular necrosis market size?

Answer: The global avascular necrosis market is expected to reach an estimated $853.8 million by 2030.

Q2. What is the growth forecast for avascular necrosis market?

Answer: The global avascular necrosis market is expected to grow with a CAGR of 5.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the avascular necrosis market?

Answer: The major drivers for this market are growing preference for less painful substitute bone grafting surgical procedures, rising preference for surgeries to treat osteonecrosis, and increasing adoption of nonsteroidal anti-inflammatory drugs.

Q4. What are the major segments for avascular necrosis market?

Answer: The future of the avascular necrosis market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.

Q5. Who are the key avascular necrosis market companies?

Answer: Some of the key avascular necrosis companies are as follows:

• Novartis
• Pfizer
• Teva Pharmaceutical
• Mylan
• Zimmer Biomet
• Merck
• Enzo Biochem
• Atnahs
• Bone Therapeutics
• Vericel

Q6. Which avascular necrosis market segment will be the largest in future?

Answer: Lucintel forecasts that non-trauma will remain the larger segment over the forecast period due to its rising usage among various treatments related to alcohol intake and abnormalities related to metabolism of bones.

Q7. In avascular necrosis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising cases of avascular necrosis among individuals, increase in geriatric population, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the avascular necrosis market by type (trauma and non-trauma), treatment (nonsteroidal anti-inflammatory drugs (NSAIDs), cholesterol lowing drugs, osteoporosis drugs, blood thinners, and others), diagnosis (imaging, biopsy, CT scan, PET, and x- ray), end use (hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?Please note: It will take 2-3 business days to deliver the report upon receipt the order.